Genentech

DNA medicine company

Genentech is a pioneering American biotechnology company founded in 1976, widely considered the first biotech firm to successfully commercialize products made using recombinant DNA technology.

Based in South San Francisco, California, the company developed landmark drugs including synthetic human insulin and growth hormone.

Genentech became a subsidiary of the Swiss pharmaceutical giant Roche in 2009 but continues to operate as a distinct research entity.

She landed a research position at Genentech after finishing her PhD.

biotech

biotechnology

Engineering using living systems

antibodies · CRISPR · bioreactor · fermentation · cloning · humanized · biosimilars · biologics · molecular

pioneer

trailblazer

First to forge ahead

breakthrough · insulin · interferon · landmark · revolutionary · proof-of-concept · commercialization

corporate

Roche

Swiss pharmaceutical corporation

stock · headquarters · Boyer · Swanson · employees · revenue · management · merger · NASDAQ · stakeholders

pharma

drug

Active chemical compound

immunotherapy · medicine · chemotherapy · vaccine · efficacy · dosage · pipeline · blockbuster · indication · formulation

Opposites
drug development methodology

GenentechPfizer

Global medication and vaccine company

Merck · Eli Lilly · chemical synthesis · GlaxoSmithKline · Bristol-Myers Squibb

therapeutic approach

Genentechtraditional medicine

Inherited therapeutic practices

herbal remedies · homeopathy · folk medicine · naturopathy · Ayurveda

innovation paradigm

GenentechBig Pharma

Major medication corporations collectively

Family

gene, genes, genetic, genetics, genetically, genome, genomic, genomics, genesis

Familiarity
Top 1,000,000
Profile
Mostly American · Concrete · Rated G